Press Release April 11, 2023 Neurofibromatosis: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market
Press Release April 11, 2023 Neurodermatitis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market|Key Companies Sanofi, Trevi Therapeutics, Galderma, Kiniksa Pharmaceuticals
Press Release April 11, 2023 Nephrotic Syndrome Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market Alderya Therapeutics, Roche, Astellas Pharmaceuticals, Novartis Pharmaceuticals, SynAct
Press Release April 11, 2023 Nephrosclerosis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market | Companies-Astellas Pharmaceuticals, Alexion Pharmaceuticals
Press Release April 11, 2023 Opioid Induced Constipation(OIC) Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market
Press Release April 11, 2023 70+ Active Companies working to develop 70+ Pipeline Therapies for Schizophrenia Treatment Landscape | Major Companies – Otsuka Pharmaceutical, Takeda, Vanda Pharmaceuticals, and Others
Press Release April 11, 2023 30+ Active Companies working to develop 35+ Pipeline Therapies for Food Allergy Treatment Landscape | Major Companies – Merck, Genentech, Novartis, and Others
Press Release April 11, 2023 80+ Active Companies working to develop 80+ Pipeline Therapies for Idiopathic Pulmonary Fibrosis Treatment Landscape | Major Companies – Roche, Novartis, Vicore Pharma, and Others.
Press Release April 11, 2023 100+ Active Companies working to develop 100+ Pipeline Therapies for Type 2 Diabetes Treatment Landscape | Major Companies – Hanmi Pharmaceuticals, Sanofi, AstraZeneca, and others
Press Release April 11, 2023 50+ Active Companies working to develop 50+ Pipeline Therapies for Dry Eye Disease Treatment Landscape | Major Companies – TearSolutions, RegeneRx Biopharmaceuticals, and others.